Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can closer exercise coaching speed recovery from concussion?

NCT ID NCT06015451

Symptom relief Sponsor: St. Olavs Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This trial tests whether a more intensive exercise program with in-person follow-up and repeated treadmill tests helps people with post-concussion symptoms and headaches recover better than a program with only phone-based follow-up. Participants will exercise at a level just below what triggers their symptoms, three to five times a week for 12 weeks. The study aims to see if the closer supervision leads to greater improvements in exercise tolerance and headache burden.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Sub-symptom threshold exercise
What this could lead to
If this works, it could point toward a more effective way to deliver exercise therapy for people recovering from mild head injuries, potentially improving recovery from exercise intolerance and reducing headache burden.
What could go wrong
This is a relatively small trial, and the results may not apply to everyone with post-concussion symptoms. Exercise could temporarily worsen symptoms, and the benefit of closer follow-up may not be significant.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 100 people

The number the study aims to enrol. It can still change while the study runs.

Started

Nov 2022

Expected to finish

Sep 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Age 18-65 years * Having sustained a minimal head injury or mild traumatic brain injury at least 2 weeks ago. * At least one postconcussion symptoms, of at least moderate degree, occurring within the first week after the head injury. * Intolerance for physical activity (self-reported and measured; including symptom exacerbation later on the test day). * Capable of giving informed consent. Exclusion Criteria: * More than 2 years since last injury. * The symptoms are better explained by other conditions. * Severe communication problems, typically due to poor knowledge of Norwegian. * Severe psychiatric, neurological, somatic, or substance abuse disorders that will make it problematic to function in a group and/or will complicate follow-up and outcome assessment. * Safety concerns according to the study medical checklist.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Brain concussion are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Brain Concussion Craniocerebral Trauma Motor Activity Post-Concussion Syndrome Post-Traumatic Headache traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Brain concussion Craniocerebral trauma Post-concussion syndrome Post-traumatic headache

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • St. Olavs Hospital, Clinic of Rehabilitation

    RECRUITING

    Trondheim, 7050, Norway

More trials for these conditions

Other studies related to the condition(s) this trial covers.